UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies

International journal of molecular sciences, 2021-01, Vol.22 (3), p.1234

2021

Volltextzugriff (PDF)

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

Expert opinion on therapeutic targets, 2019-11, Vol.23 (11), p.915-929

2019

Volltextzugriff (PDF)

Molecular mechanisms of sorafenib action in liver cancer cells

Cell cycle (Georgetown, Tex.), 2012-08, Vol.11 (15), p.2843-2855

2012

Volltextzugriff (PDF)

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

International journal of oncology, 2017-08, Vol.51 (2), p.533-544

2017

Volltextzugriff (PDF)

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

Oncotarget, 2012-03, Vol.3 (3), p.236-260

2012

Volltextzugriff (PDF)

Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment

Journal of agricultural and food chemistry, 2017-02, Vol.65 (7), p.1342-1352

2017

Volltextzugriff (PDF)

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

Cells (Basel, Switzerland), 2020-06, Vol.9 (6), p.1427

2020

Volltextzugriff (PDF)

New Insights into the Behavior of NHC-Gold Complexes in Cancer Cells

Pharmaceutics, 2023-01, Vol.15 (2), p.466

2023

Volltextzugriff (PDF)

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells

PloS one, 2013-06, Vol.8 (6), p.e65569

2013

Volltextzugriff (PDF)

Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta

Marine drugs, 2020-04, Vol.18 (4), p.209

2020

Volltextzugriff (PDF)

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma

Advances in biological regulation, 2017-08, Vol.65, p.59-76

2017

Volltextzugriff (PDF)

Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

Cell cycle (Georgetown, Tex.), 2010-04, Vol.9 (7), p.1399-1410

2010

Volltextzugriff (PDF)

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

Journal of nanobiotechnology, 2018-01, Vol.16 (1), p.3-3, Article 3

2018

Volltextzugriff (PDF)

Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells

Experimental & molecular medicine, 2007-06, Vol.39 (3), p.284-294

2007

Volltextzugriff (PDF)

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway

Cancer biology & therapy, 2007-09, Vol.6 (9), p.1457-1464

2007

Volltextzugriff (PDF)

TOP-193 Consumption of a mediterranean diet with high-polyphenol content extra-virgin olive oil (EVOO) in patients with MASLD: effects on clinical parameters and gene expression on peripheral blood mononuclear cells (PBMCs)

Journal of hepatology, 2024-06, Vol.80, p.S601-S601

2024

Volltextzugriff (PDF)

The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma

Cancer letters, 2021-10, Vol.519, p.250-262

2021

Volltextzugriff (PDF)

Prostaglandin E2 Receptors and COX Enzymes in Human Hepatocellular Carcinoma

Annals of the New York Academy of Sciences, 2009-02, Vol.1155 (1), p.300-308

2009

Volltextzugriff (PDF)

GSK-3 in liver diseases: Friend or foe?

Biochimica et biophysica acta. Molecular cell research, 2020-09, Vol.1867 (9), p.118743, Article 118743

2020

Volltextzugriff (PDF)

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

International journal of cancer, 2019-05, Vol.144 (10), p.2613-2624

2019

Volltextzugriff (PDF)

Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation

Journal of controlled release, 2017-11, Vol.266, p.47-56

2017

Volltextzugriff (PDF)

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

Cell death & disease, 2018-01, Vol.9 (2), p.28-13, Article 28

2018

Volltextzugriff (PDF)

The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells

International journal of molecular medicine, 2006-02, Vol.17 (2), p.245-252

2006

Volltextzugriff (PDF)

Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells

Biochimica et biophysica acta, 2003-12, Vol.1643 (1), p.75-83

2003

Volltextzugriff (PDF)

Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells

Biomacromolecules, 2015-12, Vol.16 (12), p.3784-3791

2015

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(43)
Humans
(35)
Animals
(19)
Female
(19)
Cell Line, Tumor
(14)
Hepatocellular Carcinoma
(14)
Rats
(13)
Apoptosis
(12)
Cancer
(12)
Liver Cancer
(10)
Proteins
(10)
Carcinoma, Hepatocellular - Pathology
(9)
Cell Biology
(9)
Cell Proliferation - Drug Effects
(9)
Immunology
(9)
Oncology
(9)
Rats, Wistar
(9)
Substance P - Pharmacology
(9)
Antineoplastic Agents - Pharmacology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

Molecular mechanisms of sorafenib action in liver cancer cells

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

New Insights into the Behavior of NHC-Gold Complexes in Cancer Cells

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells

Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma

Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway

TOP-193 Consumption of a mediterranean diet with high-polyphenol content extra-virgin olive oil (EVOO) in patients with MASLD: effects on clinical parameters and gene expression on peripheral blood mononuclear cells (PBMCs)

The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma

Prostaglandin E2 Receptors and COX Enzymes in Human Hepatocellular Carcinoma

GSK-3 in liver diseases: Friend or foe?

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells

Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells

Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells

Suchergebnisse filtern